Pharmaceutical industry - Open Access .click

Results 251 to 260 of about 537,841 (319)

Constant Enzymatic in situ Production of H2O2 for an Unspecific Peroxygenase by an l–Amino Acid Oxidase

Advanced Synthesis &Catalysis, EarlyView.
Abstract Unspecific Peroxygenases have been the subject of a lot of research in the recent past as they offer opportunities for green hydroxylation reactions using hydrogen peroxide (H2O2) as donor. A striking problem of UPOs is their low stability against their own co‐substrate H2O2. In order to prevent the deactivation, we developed an enzyme cascade
Simon Last +6 more
wiley +1 more source

Continuous Flow Technology Enabling Photochemistry

Advanced Synthesis &Catalysis, EarlyView.
Abstract The merger of continuous flow technology and modern photochemistry has enabled countless applications showcasing new opportunities for chemical synthesis demonstrating improvements in selectivity, safety, sustainability and scalability. This focused review aims to highlight a selection of recently published case studies from academic and ...
Ruairi Crawford, Marcus Baumann
wiley +1 more source

Co-creating tools for embedding meaningful patient and public involvement and engagement in real-world data and evidence research in the pharmaceutical industry setting: a multistakeholder participatory co-design study. [PDF]

BMJ Open
Dews SA +9 more
europepmc +1 more source

Asymmetric synthesis of highly substituted spiro[2H‐pyrrole‐2,3‐succinimide] derivatives by copper‐catalyzed post‐Ugi reactions

Advanced Synthesis &Catalysis, Accepted Article.
Herein we present a novel one‐por methodology for the synthesis of enantioenriched 2H‐pyrrolespirosuccinimides by copper‐catalyzed reactions on Ugi adducts derived from enantiopure α‐alkylbenzyl amines through a chirality transfer process. We have proposed a mechanism supported by density functional theory (DFT) calculations, where a hydrogen radical ...
Maria Garcia Valverde +3 more
wiley +1 more source

Interacting with the pharmaceutical industry.

The California journal of emergency medicine, 2003
openaire +3 more sources

Innovation in the pharmaceutical industry [PDF]

Journal of the Royal Society of Medicine, 2000
openaire +3 more sources

Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021. [PDF]

J R Soc Med
Murayama A, Fabbri A, Scholfield H, Ozieranski P. +3 more
europepmc +1 more source

Development of Photo‐Biocatalytic Redox System for Asymmetric Synthesis of Optically Active Amines Using Blue Light and Transaminases. A Case Study Toward Mavacamten

Advanced Synthesis &Catalysis, EarlyView.
Abstract α‐Chiral amines are versatile building blocks for the asymmetric synthesis of optically pure high‐added‐value chemicals, including pharmaceuticals, agrochemicals, and natural products. Herein, we report a one‐pot, two‐step sequential deracemization of racemic sec‐alcohols to optically enriched primary amines throught a photo‐biocatalytic ...
Natalia Antos +5 more
wiley +1 more source

Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis. [PDF]

BMJ Open
Murayama A, Higuchi K, Senoo Y.
europepmc +1 more source

Toward Sustainable Photocatalysis: Addressing Deactivation and Environmental Impact of Anodized and Sol–Gel Photocatalysts

Advanced Sustainable Systems, EarlyView.
A life‐cycle evaluation of TiO2 photocatalysts for water purification compares the effectiveness of Sol–Gel vs anodic oxides in tetracycline mineralization, targeting deactivation, regeneration, and environmental impact from a cradle‐to‐grave perspective.
Maria Vittoria Diamanti +5 more
wiley +1 more source

synthesis